Drugs / HB-AS02V
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00291980 | Mar 2006 → Oct 2007 | hepatitis B virus infection | Henogen | Completed | No outcome recorded |
| Phase 3 | NCT00291954 | Mar 2006 → Oct 2007 | hepatitis B virus infection | Henogen | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HB-AS02V | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00291980 ↗ |
| Modality | Vaccine | “Henogen hepatitis B vaccine” NCT00291954 ↗ |